Development of a DNA Vaccine Targeting Human Papillomavirus Type 16 Oncoprotein E6

Human papillomavirus (HPV), particularly type 16 (HPV-16), is present in more than 99% of cervical cancers. The HPV oncoproteins E6 and E7 are constantly expressed and therefore represent ideal targets for HPV vaccine development. We previously developed DNA vaccines encoding calreticulin (CRT) link...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Peng, Shiwen, Ji, Hongxiu, Trimble, Cornelia, He, Liangmei, Tsai, Ya-Chea, Yeatermeyer, Jessica, Boyd, David A. K., Hung, Chien-Fu, Wu, T.-C.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2004
Assuntos:
Vaccines and Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC479075/
https://ncbi.nlm.nih.gov/pubmed/15280455
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.78.16.8468-8476.2004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados